Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Journal of Endotoxin Research
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Ridings, P.
Right arrow Articles by Sugerman, H.J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ridings, P.
Right arrow Articles by Sugerman, H.J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

A synthetic lipid A analog, B464, provides significant protection against the cardiopulmonary derangements in porcine Gram-negative sepsis

P. Ridings

Departments of Surgery and Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia, Eisai Research Institute, Andover, Massachusetts, USA

A.C. Windsor

Departments of Surgery and Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia, Eisai Research Institute, Andover, Massachusetts, USA

D.P. Rossignol

Departments of Surgery and Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia, Eisai Research Institute, Andover, Massachusetts, USA

W.J. Christ

Departments of Surgery and Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia, Eisai Research Institute, Andover, Massachusetts, USA

C. Blocher

Departments of Surgery and Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia, Eisai Research Institute, Andover, Massachusetts, USA

B.J. Fisher

Departments of Surgery and Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia, Eisai Research Institute, Andover, Massachusetts, USA

A.A. Fowler

Departments of Surgery and Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia, Eisai Research Institute, Andover, Massachusetts, USA

H.J. Sugerman

Departments of Surgery and Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia, Eisai Research Institute, Andover, Massachusetts, USA

Many of the cardiopulmonary derangements associated with Gram-negative sepsis result from the activation of monocytes and macrophages by endotoxin with the resultant release of humoral mediators such as TNF{alpha}. Lipid A has been shown to retain the majority of endotoxin toxicity, however lipid A from nontoxic organisms has been shown, in vitro, to antagonize the action of other toxic endotoxin species. We examined the effects of a synthetic analog of lipid A (B464), on the evolution of hemodynamic derangements and acute lung injury following experimental Gram-negative sepsis. Anesthetized, ventilated swine were made septic with a 1 h intravenous infusion of live Pseudomonas aeruginosa and studied for 5 h. A treatment group received a bolus of B464 (100 µg/kg) prior to sepsis and a 1 h infusion (100 µg/kg/h) during the P. aeruginosa induction. A control group received simply 0.9% saline. All animals were studied for 5 h. B464 treatment failed to alter septic pulmonary hypertension or the decline in cardiac output. Late recovery from systemic hypotension was associated with reversal of arterial acidosis. Septic neutropenia was unaltered and was associated with increased lung neutrophil (PMN) sequestration measured by lung myeloperoxidase activity. However, decreased bronchoalveolar lavage protein content and improved arterial oxygen tension indicated attenuated acute lung injury in B464 treated animals. These preliminary data indicate that B464 may prove to be an effective tool in the treatment of human sepsis.

Journal of Endotoxin Research, Vol. 2, No. 2, 121-130 (1995)
DOI: 10.1177/096805199500200207


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?